Does BENDAMUSTINE Cause Tumour lysis syndrome? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Tumour lysis syndrome have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 1.1% of all adverse event reports for BENDAMUSTINE.
223
Reports of Tumour lysis syndrome with BENDAMUSTINE
1.1%
of all BENDAMUSTINE reports
53
Deaths
130
Hospitalizations
How Dangerous Is Tumour lysis syndrome From BENDAMUSTINE?
Of the 223 reports, 53 (23.8%) resulted in death, 130 (58.3%) required hospitalization, and 33 (14.8%) were considered life-threatening.
Is Tumour lysis syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Tumour lysis syndrome?
VENETOCLAX (1,057)
RITUXIMAB (1,056)
CYCLOPHOSPHAMIDE (918)
VINCRISTINE (832)
DOXORUBICIN (803)
DEXAMETHASONE (795)
ETOPOSIDE (553)
PREDNISONE (550)
CYTARABINE (407)
CARBOPLATIN (337)
Which BENDAMUSTINE Alternatives Have Lower Tumour lysis syndrome Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE